CircPAN3 mediates drug resistance in acute myeloid leukemia through the miR-153-5p/miR-183-5p-XIAP axis.
来源期刊:Experimental hematologyDOI:10.1016/j.exphem.2018.10.011
Development of innate immune cells from human pluripotent stem cells.
来源期刊:Experimental hematologyDOI:10.1016/j.exphem.2018.12.005
Deferasirox selectively induces cell death in the clinically relevant population of leukemic CD34+CD38- cells through iron chelation, induction of ROS, and inhibition of HIF1α expression.
来源期刊:Experimental hematologyDOI:10.1016/j.exphem.2018.10.010
Eltrombopag promotes DNA repair in human hematopoietic stem and progenitor cells.
来源期刊:Experimental hematologyDOI:10.1016/j.exphem.2019.03.002
Loss of EfnB1 in the osteogenic lineage compromises their capacity to support hematopoietic stem/progenitor cell maintenance.
来源期刊:Experimental hematologyDOI:10.1016/j.exphem.2018.10.004
Human acute myeloid leukemia blast-derived exosomes in patient derived xenograft mice mediate immune suppression.
来源期刊:Experimental hematologyDOI:10.1016/j.exphem.2019.07.005
Induced pluripotent stem cell modeling of malignant hematopoiesis.
来源期刊:Experimental hematologyDOI:10.1016/j.exphem.2019.01.002
Glycolytic enzyme hexokinase II is a putative therapeutic target in B cell malignant lymphoma.
来源期刊:Experimental hematologyDOI:10.1016/j.exphem.2019.09.023
Chronic graft-versus-host disease and the risk of primary disease relapse: A meta-analysis.
来源期刊:Experimental hematologyDOI:10.1016/j.exphem.2019.04.004
Targeting cell-bound MUC1 on myelomonocytic, monocytic leukemias and phenotypically defined leukemic stem cells with anti-SEA module antibodies.
来源期刊:Experimental hematologyDOI:10.1016/j.exphem.2018.12.002
ATP produced by anaerobic glycolysis is essential for enucleation of human erythroblasts.
来源期刊:Experimental hematologyDOI:10.1016/j.exphem.2019.02.004
LOSS OF FBXO11 FUNCTIONS DRIVES ACUTE MYELOID LEUKEMIA
来源期刊:Experimental HematologyDOI:10.1016/J.EXPHEM.2019.06.407
USP44 is dispensable for normal hematopoietic stem cell function, lymphocyte development, and B-cell-mediated immune response in a mouse model.
来源期刊:Experimental hematologyDOI:10.1016/j.exphem.2019.01.001
Identification of miRNAs from stem cell derived microparticles in umbilical cord blood.
来源期刊:Experimental hematologyDOI:10.1016/j.exphem.2019.11.001
Disease modeling of bone marrow failure syndromes using iPSC-derived hematopoietic stem progenitor cells.
来源期刊:Experimental hematologyDOI:10.1016/j.exphem.2019.01.006
1030 - REGULATION OF HEMATOPOIETIC AND IMMUNE ESCAPE OF AML STEM CELLS
来源期刊:Experimental HematologyDOI:10.1016/J.EXPHEM.2019.06.268
2001 - LONG-TERM EX VIVO EXPANSION OF FUNCTIONAL HEMATOPOIETIC STEM CELLS
来源期刊:Experimental HematologyDOI:10.1016/J.EXPHEM.2019.06.276
STEM CELL LIKE ERYTHROID/MEGAKARYOCYTE-PRIMED PROGENITORS EXPAND IN HUMANS IN RESPONSE TO FREQUENT PLATELET DONATION
来源期刊:Experimental HematologyDOI:10.1016/J.EXPHEM.2019.06.318
1008 - CHANGING NEIGHBOURS: BONE MARROW REMODELLING DURING AGING AND AGE-RELATED MYELOPROLIFERATIVE DISORDERS
来源期刊:Experimental HematologyDOI:10.1016/J.EXPHEM.2019.06.246
Further assessment of stochastic proliferation and its potential application to hematopoietic scaling across species.
来源期刊:Experimental hematologyDOI:10.1016/j.exphem.2019.11.003
DEVELOPMENT OF A DATA PORTAL FOR AGGREGATION AND ANALYSIS OF GENOMICS DATA IN FAMILIAL PLATELET DISORDER WITH PREDISPOSITION TO MYELOID MALIGNANCY – THE RUNX1.DB
来源期刊:Experimental HematologyDOI:10.1016/J.EXPHEM.2019.06.369
CHARACTERIZATION OF THERAPY-INSENSITIVE LSC SUBPOPULATIONS IN CHRONIC MYELOID LEUKEMIA
来源期刊:Experimental HematologyDOI:10.1016/J.EXPHEM.2019.06.458
THE MECHANISM OF ONCOGENIC MUTATIONS IN THE JUXTAMEMBRANE AND TRANSMEMBRANE REGION OF IL7RA AND TPOR/MPL
来源期刊:Experimental HematologyDOI:10.1016/J.EXPHEM.2019.06.332
Application of blood and immunodeficiency gene detection in the diagnosis of hemophagocytic lymphohistiocytosis patients.
来源期刊:Experimental HematologyDOI:10.1016/J.EXPHEM.2019.09.024
2025 - RHEUMATOID ARTHRITIS INCREASES SYMPATHETIC NERVOUS SYSTEM DRIVEN HEMATOPOIETIC STEM CELL MOBILISATION AND ATHEROGENESIS
来源期刊:Experimental HematologyDOI:10.1016/J.EXPHEM.2019.06.297
FUNCTIONAL ANALYSIS OF CD99 UPREGULATION IN ACUTE MYELOID LEUKEMIA
来源期刊:Experimental HematologyDOI:10.1016/J.EXPHEM.2019.06.322
2004 - NOVEL PRO-INFLAMMATORY AGM-ASSOCIATED MACROPHAGES ARE INVOLVED IN EMBRYONIC DEVELOPMENT OF HEMATOPOIETIC STEM CELLS
来源期刊:Experimental HematologyDOI:10.1016/J.EXPHEM.2019.06.279
2007 - RIPPING LEUKEMIAS APART: THE ROLE OF RIP KINASE 1 IN ACUTE MYELOID LEUKEMIA
来源期刊:Experimental HematologyDOI:10.1016/J.EXPHEM.2019.06.281
1022 - SYSTEMATIC GENETIC DISSECTION OF THE HEMATOPOIETIC STEM CELL NICHE IN THE FETAL LIVER
来源期刊:Experimental HematologyDOI:10.1016/J.EXPHEM.2019.06.260
Metcalf Lecture Award Manuscript-Applying niche biology to engineer T cell regenerative therapies.
来源期刊:Experimental hematologyDOI:10.1016/j.exphem.2019.11.004
2034 – RAB5C-MEDIATED ENDOCYTIC TRAFFICKING REGULATES HEMATOPOIETIC STEM AND PROGENITOR CELL DEVELOPMENT THROUGH NOTCH AND AKT SIGNALING
来源期刊:Experimental HematologyDOI:10.1016/j.exphem.2019.09.003
Lipocalin-2 levels in acute and chronic graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.
来源期刊:Experimental hematologyDOI:10.1016/j.exphem.2019.05.001
2028 - PULSATION IN BLOOD VESSELS STIMULATES MECHANOSENSITIVE AND EPIGENETIC MECHANISMS TO PROMOTE THE BIRTH OF HEMATOPOIETIC STEM CELLS
来源期刊:Experimental HematologyDOI:10.1016/J.EXPHEM.2019.06.300
INTERLEUKIN-1 RESTRICTS HSC PROLIFERATION VIA A PU.1-DEPENDENT MECHANISM
来源期刊:Experimental HematologyDOI:10.1016/J.EXPHEM.2019.06.420
2021 - CHOLINERGIC INFLUENCE OF BONE MARROW VASCULAR MICROENVIRONMENT INFLUENCES HEMATOPOIETIC STEM CELL MOBILIZATION
来源期刊:Experimental HematologyDOI:10.1016/J.EXPHEM.2019.06.293
THE TRANSCRIPTION FACTOR IRF8 EPIGENETICALLY REGULATES EARLY DENDRITIC CELL SPECIFICATION
来源期刊:Experimental HematologyDOI:10.1016/J.EXPHEM.2019.06.374
ARE THE BCL2 FAMILY INHIBITORS SUBSTRATES FOR THE MULTIDRUG RESISTANCE EFFLUX PUMP MDR1
来源期刊:Experimental HematologyDOI:10.1016/J.EXPHEM.2019.06.408
REVERSIBILITY OF MIR-125A-INDUCED SELF-RENEWAL AND EXPANSION OF HEMATOPOIETIC STEM CELLS
来源期刊:Experimental HematologyDOI:10.1016/J.EXPHEM.2019.06.401
COMBINED LENTIVIRAL- AND RNA-MEDIATED CRISPR/CAS9 DELIVERY FOR EFFICIENT AND TRACEABLE GENE EDITING IN HUMAN HEMATOPOIETIC STEM AND PROGENITOR CELLS
来源期刊:Experimental HematologyDOI:10.1016/J.EXPHEM.2019.06.326
3166 – THE ROLE OF AUTOPHAGY IN HEMATOPOIESIS AND HEMATOPOIETIC DISEASE
来源期刊:Experimental HematologyDOI:10.1016/j.exphem.2019.09.008
2031 - DELINEATING MECHANISMS OF ACQUIRED RESISTANCE TO IDH INHIBITORS IN AML
来源期刊:Experimental HematologyDOI:10.1016/J.EXPHEM.2019.06.303
1034 - EPIGENETIC REGULATION IN LEUKEMIAS: FROM BASIC BIOLOGY TO NEW THERAPIES
来源期刊:Experimental HematologyDOI:10.1016/J.EXPHEM.2019.06.272
1003 - UNDERSTANDING AND TARGETING THE STEM CELL ORIGINS OF MYELOID MALIGNANCIES
来源期刊:Experimental HematologyDOI:10.1016/J.EXPHEM.2019.06.241
2009 - DISRUPTING THE MASTER REGULATORS OF BLOOD EMERGENCE IN THE MOUSE EMBRYO
来源期刊:Experimental HematologyDOI:10.1016/J.EXPHEM.2019.06.283
IDENTIFICATION OF POTENT BH3-MIMETIC COMBINATIONS TARGETING PRO-SURVIVAL PATHWAYS IN HUMAN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
来源期刊:Experimental HematologyDOI:10.1016/J.EXPHEM.2019.06.411
MESENCHYMAL STEM CELLS SUPPRESS LEUKEMIA VIA MACROPHAGE-MEDIATED BONE MARROW NICHE RESTORATION
来源期刊:Experimental HematologyDOI:10.1016/J.EXPHEM.2019.06.463
2000 - MONOLINEAGE ORIGIN OF RELAPSE FOLLOWING MULTILINEAGE DIFFERENTIATION THERAPY OF ACUTE MYELOID LEUKEMIA
来源期刊:Experimental HematologyDOI:10.1016/J.EXPHEM.2019.06.275
DACH1 DOWNREGULATION DELINEATE A LYMPHOID PRIMED PROGENITOR (LPP) POPULATION WITHIN THE MPP4 CLUSTER
来源期刊:Experimental HematologyDOI:10.1016/J.EXPHEM.2019.06.448
ENHANCED ENRICHMENT OF SMALL CD31+ BLAST-LIKE HUMAN CORD BLOOD CELLS
来源期刊:Experimental HematologyDOI:10.1016/J.EXPHEM.2019.06.362
MECHANISM OF IMPROVED HUMAN HEMATOPOIETIC STEM CELL ENGRAFTMENT IN NON-CONDITIONED NSGW41 MICE
来源期刊:Experimental HematologyDOI:10.1016/J.EXPHEM.2019.06.425